[1]张建祖.口腔癌流行病学研究进展[J].包头医学院学报,2013,29(1):114-115.
ZHANG JZ.Progress in epidemiology of oral cancer[J].Journal of Baotou Medical College,2013,29(1):114-115.
[2]JOHNSON NW,JAYASEKARA P,AMARASINGHE AAHK.Squamous cell carcinoma and precursor lesions of the oral cavity:epidemiology and aetiology[J].Periodontology,2000,2011,57(1):19-37.
[3]VAN DER WAAL I.Are we able to reduce the mortality and morbidity of oral cancer.Some considerations[J].Medicina Oral,Patologia Oral Cirugia Bucal,2013,18(1):e33-e37.
[4]ALLAVENA P,GARLANDA C,BORRELLO MG,et al.Pathways connecting inflammation and cancer[J].Current Opinion in Genetics & Development,2008,18(1):3-10.
[5]王琨,崔博淼,李燕,等.人体微生物组的肿瘤诱导作用及机制的研究进展[J].生命科学,2015,27(9):1155-1159.
WANG K,CUI BM,LI Y,et al.Research progress on tumor induction and mechanism of human microbiome[J].Life Sciences,2015,27(9):1155-1159.
[6]SINGH N,BABY D,RAJGURU JP,et al.Inflammation and cancer[J].Annals of African Medicine,2019,18(3):121-126.
[7]HIRANO T.IL-6 in inflammation,autoimmunity and cancer[J].International Immunology,2021,33(3):127-148.
[8]HE F,ANTONUCCI L,KARIN M.NRF2 as a regulator of cell metabolism and inflammation in cancer[J].Carcinogenesis,2020,41(4):405-416.
[9]童欢欢,刘杉杉,李京京,等.癌症病人症状群炎症机制的研究进展[J].护理研究,2021,35(7):1184-1188.
TONG HH,LIU SS,LI JJ,et al.Research progress on inflammatory mechanism of symptom population in cancer patients[J].Nursing Research,2021,35(7):1184-1188.
[10]SU SC,CHANG LC,HUANG HD,et al.Oral microbial dysbiosis and its performance in predicting oral cancer[J].Carcinogenesis,2021,42(1):127-135.
[11]HE A,SHAO J,ZHANG Y,et al.CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway[J].Oncotarget,2017,8(20):33214-33224.
[12]TANIGUCHI K,KARIN M.NF-κB,inflammation,immunity and cancer:coming of age[J].Nature Reviews Immunology,2018,18(5):309-324.
[13]PENG HY,HSIAO JR,CHOU ST,et al.MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking[J].Neoplasia,2020,22(11):554-565.
[14]TAFANI M,DE SANTIS E,COPPOLA L,et al.Bridging hypoxia,inflammation and estrogen receptors in thyroid cancer progression[J].Biomedicine & Pharmacotherapy,2014,68(1):1-5.
[15]PEDDAREDDIGARI VG,WANG D,DUBOIS RN.The tumor microenvironment in colorectal carcinogenesis[J].Cancer Microenvironment,2010,3(1):149-166.
[16]李博磊,李龙江,周学东,等.口腔微生物与口腔癌[J].口腔医学研究,2015,31(6):558-563.
LI BL,LI LJ,ZHOU XD,et al.Oral microbiology and oral cancer[J].Research in Stomatology,2015,31(6):558-563.
[17]ATANASOVA KR,YILMAZ.Looking in the porphyromonas gingivalis cabinet of curiosities:the microbium,the host and cancer association[J].Molecular Oral Microbiology,2014,29(2):55-66.
[18]GROEGER S,DOMANN E,GONZALES JR,et al.B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by porphyromonas gingivalis[J].Immunobiology,2011,216(12):1302-1310.
[19]刘明.牙龈卟啉单胞菌与口腔鳞状细胞癌的相关性研究[J].中华肿瘤防治杂志,2018,25(S1):23-25.
LIU M.Correlation between porphyromonas gingivalis and oral squamous cell carcinoma[J].Chinese Journal of Cancer Prevention and Treatment,2018,25(S1):23-25.
[20]张庆慧,刘晓波,文卉,等.牙龈卟啉单胞菌脂多糖促进食管鳞癌细胞的增殖和迁移[J].现代肿瘤医学,2021,29(23):4122-4128.
ZHANG QH,LIU XB,WEN H,et al.Porphyromonas gingivalis lipopolysaccharide promotes the proliferation and migration of esophageal squamous cell carcinoma cells[J].Modern Oncology,2021,29(23):4122-4128.
[21]KO MS,YUN JY,BAEK IJ,et al.Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice[J].Autophagy,2021,17(5):1205-1221.
[22]KELLEY N,JELTEMA D,DUAN Y,et al.The NLRP3 inflammasome:an overview of mechanisms of activation and regulation[J].International Journal of Molecular Sciences,2019,20(13):3328-3385.
[23]PAIK S,KIM JK,SILWAL P,et al.An update on the regulatory mechanisms of NLRP3 inflammasome activation[J].Cellular & Molecular Immunology,2021,18(5):1141-1160.
[24]HUANG Y,XU W,ZHOU R.NLRP3 inflammasome activation and cell death [J].Cellular & Molecular Immunology,2021,18(9):2114-2127.
[25]RATHINAM VAK,ZHAO Y,SHAO F.Innate immunity to intracellular LPS [J].Nature Immunology,2019,20(5):527-533.
[26]MATIKAINEN S,NYMAN TA,CYPRYK W.Function and regulation of noncanonical Caspase-4/5/11 inflammasome[J].Journal of Immunology,2020,204(12):3063-3069.
[27]HAGAR JA,POWELL DA,AACHOUI Y,et al.Cytoplasmic LPS activates caspase-11:implications in TLR4-independent endotoxic shock[J].Science,2013,341(6151):1250-1253.
[28]XIAO L,LI X,CAO P,et al.Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway[J].Journal of Experimental & Clinical Cancer Research,2022,41(1):1-20.
[29]FENG X,LUO Q,WANG H,et al.MicroRNA-22 suppresses cell proliferation,migration and invasion in oral squamous cell carcinoma by targeting NLRP3[J].Journal of Cellular Physiology,2018,233(9):6705-6713.
[30]LIVAK KJ,SCHMITTGEN TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] Method[J].Methods,2001,25(4):402-408.
[31]LAX AJ.Opinion:Bacterial toxins and cancer-a case to answer[J].Nature Reviews Microbiology,2005,3(4):343-349.
[32]SRINIVASPRASAD V,DINESHSHANKAR J,SATHIYAJEEVA J,et al.Liaison between micro-organisms and oral cancer[J].Journal of Pharmacy & Bioallied Sciences,2015,7(Suppl 2):S354-S360.
[33]SUN J,TANG Q,YU S,et al.Role of the oral microbiota in cancer evolution and progression[J].Cancer Medicine,2020,9(17):6306-6321.
[34]PUSHALKAR S,MANE SP,JI X,et al.Microbial diversity in saliva of oral squamous cell carcinoma[J].FEMS Immunology and Medical Microbiology,2011,61(3):269-277.
[35]HAJISHENGALLIS G,CHAVAKIS T.Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities[J].Nature Reviews Immunology,2021,21(7):426-440.
[36]SARESELLA M,LA RF,PIANCONE F,et al.The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease[J].Molecular Neurodegeneration,2016,11(1):1-14.
[37]CHENG R,FENG Y,ZHANG R,et al.The extent of pyroptosis varies in different stages of apical periodontitis[J].Biochimica et Biophysica Acta(BBA)-Molecular Basis of Disease,2018,1864(1):226-237.
[38]XU Z,WANG H,QIN Z,et al.NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1[J].Cell Death Discovery,2021,7(1):1-9.
[39]SHARMA BR,KANNEGANTI TD.NLRP3 inflammasome in cancer and metabolic diseases[J].Nature Immunology,2021,22(5):550-559.